284 related articles for article (PubMed ID: 34873015)
21. Anti-PL-7, anti-Ro/SSA, anti-Mi-2, and anti-TIF1-γ correlate with specific patterns of histopathologic features in dermatomyositis: An analysis of 39 skin biopsy specimens from 25 patients.
Bennett R; Bradley K; Stevanovic M; McFadden JR; Chaudhari AS; Ramos-Rodriguez AJ; Yan S; Momtahen S; LeBlanc RE; Cloutier JM; Salem I; Grand DG; Hodson EL; Sriharan A
J Cutan Pathol; 2024 Apr; 51(4):317-326. PubMed ID: 38158735
[TBL] [Abstract][Full Text] [Related]
22. Edematous myositis: a clinical presentation first suggesting dermatomyositis diagnosis.
Duchesne M; Leonard-Louis S; Landon-Cardinal O; Anquetil C; Mariampillai K; Monzani Q; Benveniste O; Allenbach Y
Brain Pathol; 2020 Sep; 30(5):867-876. PubMed ID: 32323412
[TBL] [Abstract][Full Text] [Related]
23. Comparison of Muscle Biopsy Features with Myositis Autoantibodies in Inflammatory Myopathies: A Pilot Experience.
Gudipati A; Rifat S; Uppin M; Jabeen A; Mathukumalli NL; Yareeda S; Kayidhi S; Pyal A; Dhamne M; Reddy YM
Ann Indian Acad Neurol; 2023; 26(4):408-418. PubMed ID: 37970294
[TBL] [Abstract][Full Text] [Related]
24. [A case of dermatomyositis positive for anti-nuclear matrix protein 2 antibody without dermatologic symptoms].
Takeuchi E; Hirozawa D; Okiyama N; Inoue M; Nishino I; Sugai F
Rinsho Shinkeigaku; 2021 Apr; 61(4):258-261. PubMed ID: 33762494
[TBL] [Abstract][Full Text] [Related]
25. Serum levels of anti-transcriptional intermediary factor 1-γ autoantibody associated with the clinical, pathological characteristics and outcomes of patients with dermatomyositis.
Zhang L; Yang H; Yang H; Liu H; Tian X; Jiang W; Peng Q; Wang G; Lu X
Semin Arthritis Rheum; 2022 Aug; 55():152011. PubMed ID: 35489170
[TBL] [Abstract][Full Text] [Related]
26. Contribution of Complement, Microangiopathy and Inflammation in Idiopathic Inflammatory Myopathies.
Honda M; Shimizu F; Sato R; Nakamori M
J Neuromuscul Dis; 2024; 11(1):5-16. PubMed ID: 38143369
[TBL] [Abstract][Full Text] [Related]
27. Transcriptional derepression of CHD4/NuRD-regulated genes in the muscle of patients with dermatomyositis and anti-Mi2 autoantibodies.
Pinal-Fernandez I; Milisenda JC; Pak K; Muñoz-Braceras S; Casal-Dominguez M; Torres-Ruiz J; Dell'Orso S; Naz F; Gutierrez-Cruz G; Duque-Jaimez Y; Matas-Garcia A; Padrosa J; Garcia-Garcia FJ; Guitart-Mampel M; Garrabou G; Trallero-Araguás E; Walitt B; Paik JJ; Albayda J; Christopher-Stine L; Lloyd TE; Grau-Junyent JM; Selva-O'Callaghan A; Mammen AL
Ann Rheum Dis; 2023 Aug; 82(8):1091-1097. PubMed ID: 37130727
[TBL] [Abstract][Full Text] [Related]
28. The Prevalence of Individual Histopathologic Features Varies according to Autoantibody Status in Muscle Biopsies from Patients with Dermatomyositis.
Pinal-Fernandez I; Casciola-Rosen LA; Christopher-Stine L; Corse AM; Mammen AL
J Rheumatol; 2015 Aug; 42(8):1448-54. PubMed ID: 26443871
[TBL] [Abstract][Full Text] [Related]
29. Myofiber HLA-DR expression is a distinctive biomarker for antisynthetase-associated myopathy.
Aouizerate J; De Antonio M; Bassez G; Gherardi RK; Berenbaum F; Guillevin L; Berezne A; Valeyre D; Maisonobe T; Dubourg O; Cosnes A; Benveniste O; Authier FJ
Acta Neuropathol Commun; 2014 Oct; 2():154. PubMed ID: 25339355
[TBL] [Abstract][Full Text] [Related]
30. Myxovirus resistance protein A (MxA) expression in myositides: Sarcoplasmic expression is common in both dermatomyositis and lupus myositis.
Xing C; Trivedi J; Bitencourt N; Burns DK; Reisch JS; Cai C
Muscle Nerve; 2024 May; 69(5):548-555. PubMed ID: 38372203
[TBL] [Abstract][Full Text] [Related]
31. [Myositis-specific autoantibodies].
Fujimoto M
Brain Nerve; 2013 Apr; 65(4):449-60. PubMed ID: 23568993
[TBL] [Abstract][Full Text] [Related]
32. Clinical features of anti-TIF1-α antibody-positive dermatomyositis patients are closely associated with coexistent dermatomyositis-specific autoantibodies and anti-TIF1-γ or anti-Mi-2 autoantibodies.
Muro Y; Ishikawa A; Sugiura K; Akiyama M
Rheumatology (Oxford); 2012 Aug; 51(8):1508-13. PubMed ID: 22539482
[TBL] [Abstract][Full Text] [Related]
33. [Comparison of clinical characteristics and laboratory parameters of patients with dermatomyositis-specific autoantibodies and autoantibody-negative patients].
Bodoki L; Budai D; Nagy-Vincze M; Griger Z; Betteridge Z; Dankó K
Orv Hetil; 2015 Sep; 156(36):1451-9. PubMed ID: 26320599
[TBL] [Abstract][Full Text] [Related]
34. The pattern of MHC class I expression in muscle biopsies from patients with myositis and other neuromuscular disorders.
Milisenda JC; Pinal-Fernandez I; Lloyd TE; Grau-Junyent JM; Christopher-Stine L; Corse AM; Mammen AL
Rheumatology (Oxford); 2023 Sep; 62(9):3156-3160. PubMed ID: 36707996
[TBL] [Abstract][Full Text] [Related]
35. Clinical subsets of juvenile dermatomyositis classified by myositis-specific autoantibodies: Experience at a single center in Japan.
Iwata N; Nakaseko H; Kohagura T; Yasuoka R; Abe N; Kawabe S; Sugiura S; Muro Y
Mod Rheumatol; 2019 Sep; 29(5):802-807. PubMed ID: 30092736
[No Abstract] [Full Text] [Related]
36. Integrated Diagnosis Project for Inflammatory Myopathies: An association between autoantibodies and muscle pathology.
Suzuki S; Uruha A; Suzuki N; Nishino I
Autoimmun Rev; 2017 Jul; 16(7):693-700. PubMed ID: 28479486
[TBL] [Abstract][Full Text] [Related]
37. Histological heterogeneity in a large clinical cohort of juvenile idiopathic inflammatory myopathy: analysis by myositis autoantibody and pathological features.
Yasin SA; Schutz PW; Deakin CT; Sag E; Varsani H; Simou S; Marshall LR; Tansley SL; McHugh NJ; Holton JL; Wedderburn LR; Jacques TS;
Neuropathol Appl Neurobiol; 2019 Aug; 45(5):495-512. PubMed ID: 30378704
[TBL] [Abstract][Full Text] [Related]
38. Histopathological features of systemic sclerosis-associated myopathy: A scoping review.
Lefebvre F; Giannini M; Ellezam B; Leclair V; Troyanov Y; Hoa S; Bourré-Tessier J; Satoh M; Fritzler MJ; Senécal JL; Hudson M; Meyer A; Landon-Cardinal O
Autoimmun Rev; 2021 Jul; 20(7):102851. PubMed ID: 33971337
[TBL] [Abstract][Full Text] [Related]
39. Updates on the Immunopathology in Idiopathic Inflammatory Myopathies.
Uruha A; Goebel HH; Stenzel W
Curr Rheumatol Rep; 2021 Jul; 23(7):56. PubMed ID: 34212266
[TBL] [Abstract][Full Text] [Related]
40. A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy.
Satoh M; Tanaka S; Ceribelli A; Calise SJ; Chan EK
Clin Rev Allergy Immunol; 2017 Feb; 52(1):1-19. PubMed ID: 26424665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
